|
| cleomiscosin A Basic information |
Product Name: | cleomiscosin A | Synonyms: | (2R,3R)-rel-2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-9H-pyrano[2,3-f]-1,4-benzodioxin-9-one;NSC 346197;cleomiscosin A;9H-Pyrano[2,3-f]-1,4-benzodioxin-9-one,2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-,(2R,3R)-rel-;(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one | CAS: | 76948-72-6 | MF: | C20H18O8 | MW: | 386.35 | EINECS: | | Product Categories: | | Mol File: | 76948-72-6.mol | |
| cleomiscosin A Chemical Properties |
Melting point | 245-247℃ | Boiling point | 632.7±55.0 °C(Predicted) | density | 1.403 | storage temp. | -20°C Freezer, Under inert atmosphere | solubility | Acetonitrile (Slightly, Heated), Methanol (Slightly), Pyridine (Slightly) | pka | 9.65±0.35(Predicted) | form | Solid | color | White to Off-White | LogP | 2.161 (est) |
| cleomiscosin A Usage And Synthesis |
Uses | Cleomiscosin A is a known coumarinolignan and an important constituent of the methanolic extract of Hyoscyamus niger seeds (MHN) responsible for anti-inflammatory activity. | Definition | ChEBI: An organic heterotricyclic compound that is 2,3-dihydro-9H-[1,4]dioxino[2,3-h]chromen-9-one substituted by 4-hydroxy-3-methoxy phenyl group at position 3, a hydroxymethyl group at position 2 and a methoxy group at position 5
(the 2R,3R stereoisomer). It exhibits anti-inflammatory activity. | target | LDL | TNF-α |
| cleomiscosin A Preparation Products And Raw materials |
|